Publications by authors named "YingNan Yu"

Claim this Profile
M
MAP4 phosphorylation induced by ARID1A loss sensitizes colorectal cancer cells to EMP.
Lei Pan, Danzhu Wu, Yilin He, Kejin Wang, Yingyi Zeng, Yingnan Yu

Cell Death Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disulfiram activates autophagy via proteasome inhibition and c-Fos/beclin-1 upregulation, synergizing with chloroquine.
Kejin Wang, Zhen Wang, Wenxuan Peng, Gen Li, Honglin Xiao, Yingnan Yu

Cell Death Discov· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ARID1A loss enhances sensitivity to c-MET inhibition by dual targeting of GPX4 and iron homeostasis, inducing ferroptosis.
Xu Zhang, Zihuan Wang, Yilin He, Kejin Wang, Cheng Xiang, Yingnan Yu

Cell Death Differ· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends and emerging frontiers of mesenchymal stem cells in intervertebral disc degeneration: a bibliometric analysis (2000-2024).
Jian Zhao, Shuwen Li, Jie Cheng, Xiang Xu, Ming Bai, Yingnan Yu

Front Med (Lausanne)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ARID1A loss sensitizes colorectal cancer cells to floxuridine.
Cheng Xiang, Zhen Wang, Yingnan Yu, Zelong Han, Jingyi Lu

Neoplasia· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic targeting of ARID1A-deficient cancer cells with RITA (Reactivating p53 and inducing tumor apoptosis).
Zihuan Wang, Xu Zhang, Yuchen Luo, Yijiang Song, Cheng Xiang, Yingnan Yu

Cell Death Dis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of LINC-PINT polymorphisms with lumbar disc herniation risk among Chinese Han population: a case control study.
Yimin Wu, Ming Bai, Yingnan Yu, Yupeng Wang, Yuan Zhang

J Orthop Surg Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetics of irinotecan, doxorubicin and docetaxel transporters in Asian and Caucasian cancer patients: a comparative review.
Sylvia Chen, Natalia Sutiman, Clara Zhenxian Zhang, Yingnan Yu, Shirley Lam

Drug Metab Rev· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complement component 1, q subcomponent binding protein is a marker for proliferation in breast cancer.
Olivia Jane Scully, Yingnan Yu, Agus Salim, Aye Aye Thike, George Wai-Cheong Yip

Exp Biol Med (Maywood)· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methotrexate chemotherapy triggers touch-evoked pain and increased CGRP-positive sensory fibres in the tibial periosteum of young rats.
Fiona H Zhou, Yingnan Yu, Xin-Fu Zhou, Cory J Xian

Bone· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Y-box binding protein 1 is correlated with lymph node metastasis in intestinal-type gastric cancer.
TianTian Guo, YingNan Yu, George Wai-Cheong Yip, Gyeong Hun Baeg, Aye Aye Thike

Histopathology· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer metastasis.
Olivia Jane Scully, Boon-Huat Bay, George Yip, Yingnan Yu

Cancer Genomics Proteomics· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep).
Lai Ling Cheng, Yoko Itahana, Zheng Deng Lei, Na-Yu Chia, Yonghui Wu, Yingnan Yu, Qiang Yu

Clin Cancer Res· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surmounting chemoresistance by targeting the Y-box binding protein-1.
Ikuyo Inoue, Ken Matsumoto, Yingnan Yu, Boon-Huat Bay

Anat Rec (Hoboken)· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.
Ying-Nan Yu, George Wai-Cheong Yip, Puay-Hoon Tan, Aye Aye Thike, Ken Matsumoto

Int J Oncol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silencing the Peroxiredoxin III gene inhibits cell proliferation in breast cancer.
Pei-Jou Chua, Eng-Hong Lee, Yingnan Yu, George Wai-Cheong Yip, Puay-Hoon Tan

Int J Oncol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protect effect of bicyclol on cisplatin-induced nephrotoxicity in mice.
Ying-Nan Yu, Hui Chen, Yan Li

Arch Toxicol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of bicyclol on cisplatin-induced hepatotoxicity in the hepatocarcinoma 22 tumour-bearing mice.
Ying-Nan Yu, Hui Chen, Yan Li

Basic Clin Pharmacol Toxicol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Effect of bicyclol on gene expression profiles in mice with liver injury induced by concanavalin A].
Ying-Nan Yu, Jiang Guo, Ye Li, Yuan Hong, Kang Li

Yao Xue Xue Bao· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis